Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ.DE)
EUR 52.95
(-0.09%)
EUR 52.95
(-0.09%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 215.27 Million EUR | 5.94% |
| 2022 | 203.2 Million EUR | 30.93% |
| 2021 | 155.2 Million EUR | 8.47% |
| 2020 | 143.08 Million EUR | 6.15% |
| 2019 | 134.79 Million EUR | 28.16% |
| 2018 | 105.17 Million EUR | 5.73% |
| 2017 | 99.47 Million EUR | 11.28% |
| 2016 | 89.38 Million EUR | -2.85% |
| 2015 | 92 Million EUR | -0.9% |
| 2014 | 92.83 Million EUR | 5.16% |
| 2013 | 88.28 Million EUR | 13.95% |
| 2012 | 77.47 Million EUR | 6.9% |
| 2011 | 72.47 Million EUR | 2.27% |
| 2010 | 70.86 Million EUR | -5.82% |
| 2009 | 75.24 Million EUR | 34.42% |
| 2008 | 55.97 Million EUR | 77.99% |
| 2007 | 31.45 Million EUR | 11.25% |
| 2006 | 28.26 Million EUR | -11.78% |
| 2005 | 32.04 Million EUR | 96.48% |
| 2004 | 16.3 Million EUR | -3.46% |
| 2003 | 16.89 Million EUR | 0.54% |
| 2002 | 16.8 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 219.51 Million EUR | 1.97% |
| 2024 Q2 | 222.87 Million EUR | 1.53% |
| 2023 Q2 | 219.26 Million EUR | 8.63% |
| 2023 Q3 | 218.53 Million EUR | -0.33% |
| 2023 FY | 215.27 Million EUR | 5.94% |
| 2023 Q4 | 215.27 Million EUR | -1.5% |
| 2023 Q1 | 201.83 Million EUR | -0.68% |
| 2022 Q1 | 159.65 Million EUR | 2.87% |
| 2022 Q3 | 185.39 Million EUR | 5.84% |
| 2022 Q4 | 203.2 Million EUR | 9.61% |
| 2022 Q2 | 175.16 Million EUR | 9.71% |
| 2022 FY | 203.2 Million EUR | 30.93% |
| 2021 Q1 | 143.4 Million EUR | 0.22% |
| 2021 Q4 | 155.2 Million EUR | 6.38% |
| 2021 Q2 | 144.16 Million EUR | 0.53% |
| 2021 Q3 | 145.89 Million EUR | 1.2% |
| 2021 FY | 155.2 Million EUR | 8.47% |
| 2020 FY | 143.08 Million EUR | 6.15% |
| 2020 Q1 | 130.43 Million EUR | -3.23% |
| 2020 Q2 | 125.73 Million EUR | -3.6% |
| 2020 Q3 | 134.15 Million EUR | 6.69% |
| 2020 Q4 | 143.08 Million EUR | 6.66% |
| 2019 FY | 134.79 Million EUR | 28.16% |
| 2019 Q1 | 122.33 Million EUR | 16.32% |
| 2019 Q2 | 118.92 Million EUR | -2.79% |
| 2019 Q4 | 134.79 Million EUR | 10.71% |
| 2019 Q3 | 121.76 Million EUR | 2.39% |
| 2018 Q3 | 95.98 Million EUR | 0.23% |
| 2018 Q1 | 96.64 Million EUR | -2.84% |
| 2018 FY | 105.17 Million EUR | 5.73% |
| 2018 Q4 | 105.17 Million EUR | 9.57% |
| 2018 Q2 | 95.76 Million EUR | -0.91% |
| 2017 Q2 | 99.27 Million EUR | 14.93% |
| 2017 Q1 | 86.38 Million EUR | -3.37% |
| 2017 FY | 99.47 Million EUR | 11.28% |
| 2017 Q4 | 99.47 Million EUR | 8.91% |
| 2017 Q3 | 91.33 Million EUR | -8.0% |
| 2016 Q3 | 86.2 Million EUR | 0.16% |
| 2016 FY | 89.38 Million EUR | -2.85% |
| 2016 Q4 | 89.38 Million EUR | 3.69% |
| 2016 Q2 | 86.06 Million EUR | -3.04% |
| 2016 Q1 | 88.76 Million EUR | -3.52% |
| 2015 FY | 92 Million EUR | -0.9% |
| 2015 Q1 | 90.5 Million EUR | -2.51% |
| 2015 Q2 | 90.09 Million EUR | -0.45% |
| 2015 Q3 | 89.77 Million EUR | -0.36% |
| 2015 Q4 | 92 Million EUR | 2.49% |
| 2014 Q1 | 86.11 Million EUR | -2.45% |
| 2014 Q2 | 82.61 Million EUR | -4.06% |
| 2014 Q3 | 85.83 Million EUR | 3.89% |
| 2014 Q4 | 92.83 Million EUR | 8.16% |
| 2014 FY | 92.83 Million EUR | 5.16% |
| 2013 Q2 | 72.98 Million EUR | -2.27% |
| 2013 FY | 88.28 Million EUR | 13.95% |
| 2013 Q4 | 88.28 Million EUR | 11.59% |
| 2013 Q3 | 79.11 Million EUR | 8.41% |
| 2013 Q1 | 74.67 Million EUR | -3.62% |
| 2012 Q1 | 69.15 Million EUR | -4.58% |
| 2012 FY | 77.47 Million EUR | 6.9% |
| 2012 Q4 | 77.47 Million EUR | 7.71% |
| 2012 Q3 | 71.92 Million EUR | 4.36% |
| 2012 Q2 | 68.91 Million EUR | -0.34% |
| 2011 Q2 | 64.64 Million EUR | -4.69% |
| 2011 Q1 | 67.82 Million EUR | -4.29% |
| 2011 Q4 | 72.47 Million EUR | 5.55% |
| 2011 FY | 72.47 Million EUR | 2.27% |
| 2011 Q3 | 68.66 Million EUR | 6.22% |
| 2010 Q1 | 93.03 Million EUR | 23.64% |
| 2010 Q3 | 72.77 Million EUR | -4.46% |
| 2010 Q4 | 70.86 Million EUR | -2.63% |
| 2010 FY | 70.86 Million EUR | -5.82% |
| 2010 Q2 | 76.17 Million EUR | -18.12% |
| 2009 Q4 | 75.24 Million EUR | 0.0% |
| 2009 FY | 75.24 Million EUR | 34.42% |
| 2008 FY | 55.97 Million EUR | 77.99% |
| 2007 FY | 31.45 Million EUR | 11.25% |
| 2006 FY | 28.26 Million EUR | -11.78% |
| 2005 FY | 32.04 Million EUR | 96.48% |
| 2004 FY | 16.3 Million EUR | -3.46% |
| 2003 FY | 16.89 Million EUR | 0.54% |
| 2002 FY | 16.8 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| aap Implantate AG | 8.62 Million EUR | -2395.896% |
| Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | 88.346% |
| Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | 88.346% |
| elexxion AG | 4567.05 EUR | -4713467.839% |
| Geratherm Medical AG | 11.67 Million EUR | -1743.174% |
| Koninklijke Philips N.V. | 17.34 Billion EUR | 98.759% |
| Stratec SE | 246.2 Million EUR | 12.564% |
| Siemens Healthineers AG | 28.55 Billion EUR | 99.246% |